Role of neutrophils in type 2 diabetes and associated atherosclerosis.
Role of neutrophils in type 2 diabetes and associated atherosclerosis.
复制标题
DOI:
10.1016/j.biocel.2021.106098
复制
发表时间:
2021-12
期刊:
影响因子:
--
通讯作者:
Galkina EV
中科院分区:
文献类型:
--
作者:
Keeter WC;Moriarty AK;Galkina EV
The development of cardiovascular diseases associated with Type-2 diabetes remains one of the most challenging public health burdens in the developed world. Early onset of metabolic deficiencies, namely dysregulated glucose homeostasis, peripheral insulin resistance, and impaired insulin production are accompanied by both innate and adaptive immune responses that culminate in a state of chronic, low-grade inflammation. Neutrophils are a critical component of the innate immune system which offer frontline defense against pathogens through a variety of potent effector functions. Recent data indicate an essential role of neutrophils in various disease processes that contribute to the development of Type-2 diabetes and atherosclerosis. In this brief review, we aim to distill the most relevant clinical and pre-clinical literature that investigates the role of neutrophils as an important mediator for the Type-2 diabetes/atherosclerosis connection.
登录
查看更多内容
影响因子:
29
作者:
Deng T;Lyon CJ;Minze LJ;Lin J;Zou J;Liu JZ;Ren Y;Yin Z;Hamilton DJ;Reardon PR;Sherman V;Wang HY;Phillips KJ;Webb P;Wong ST;Wang RF;Hsueh WA
通讯作者:
Hsueh WA
影响因子:
3.7
作者:
Margaryan S;Witkowicz A;Arakelyan A;Partyka A;Karabon L;Manukyan G
通讯作者:
Manukyan G
DOI:
10.1084/jem.20100239
发表时间:
2010-08-30
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Li P;Li M;Lindberg MR;Kennett MJ;Xiong N;Wang Y
通讯作者:
Wang Y
影响因子:
2.7
作者:
Lou M;Luo P;Tang R;Peng Y;Yu S;Huang W;He L
通讯作者:
He L
DOI:
10.1056/nejmoa1603827
发表时间:
2016-07-28
期刊:
The New England journal of medicine
影响因子:
--
作者:
Marso SP;Daniels GH;Brown-Frandsen K;Kristensen P;Mann JF;Nauck MA;Nissen SE;Pocock S;Poulter NR;Ravn LS;Steinberg WM;Stockner M;Zinman B;Bergenstal RM;Buse JB;LEADER Steering Committee;LEADER Trial Investigators
通讯作者:
LEADER Trial Investigators